Cargando…

The effect of the Covid-19 shutdown on glycemic testing and control

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic caused a halt to in-person ambulatory care. We evaluated how the reduction in access to care affected HbA1c testing and patient HbA1c levels. METHODS: HbA1c data from 11 institutions were extracted to compare testing volume and the percent...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Anu, Greene, Dina N., Chambliss, Allison B., Farnsworth, Christopher W., French, Deborah, Herman, Daniel S., Kavsak, Peter A., Merrill, Anna E., (Margaret) Lo, Sheng-Ying, Lyon, Martha E., Winston-McPherson, Gabrielle, Pearson, Lauren N., SoRelle, Jeffrey A., Waring, Avantika C., Schmidt, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080532/
https://www.ncbi.nlm.nih.gov/pubmed/33932408
http://dx.doi.org/10.1016/j.cca.2021.04.018
_version_ 1783685446303219712
author Sharma, Anu
Greene, Dina N.
Chambliss, Allison B.
Farnsworth, Christopher W.
French, Deborah
Herman, Daniel S.
Kavsak, Peter A.
Merrill, Anna E.
(Margaret) Lo, Sheng-Ying
Lyon, Martha E.
Winston-McPherson, Gabrielle
Pearson, Lauren N.
SoRelle, Jeffrey A.
Waring, Avantika C.
Schmidt, Robert L.
author_facet Sharma, Anu
Greene, Dina N.
Chambliss, Allison B.
Farnsworth, Christopher W.
French, Deborah
Herman, Daniel S.
Kavsak, Peter A.
Merrill, Anna E.
(Margaret) Lo, Sheng-Ying
Lyon, Martha E.
Winston-McPherson, Gabrielle
Pearson, Lauren N.
SoRelle, Jeffrey A.
Waring, Avantika C.
Schmidt, Robert L.
author_sort Sharma, Anu
collection PubMed
description BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic caused a halt to in-person ambulatory care. We evaluated how the reduction in access to care affected HbA1c testing and patient HbA1c levels. METHODS: HbA1c data from 11 institutions were extracted to compare testing volume and the percentage of abnormal results between a pre-pandemic period (January-June 2019, period 1) and a portion of the COVID-19 pandemic period (Jan-June 2020, period 2). HbA1c results greater than 6.4% were categorized as abnormal. RESULTS: HbA1C testing volumes decreased in March, April and May by 23, 61 and 40% relative to the corresponding months in 2019. The percentage of abnormal results increased in April, May and June (25, 23, 9%). On average, we found that the frequency of abnormal results increased by 0.31% for every 1% decrease in testing volume (p < 0.0005). CONCLUSION: HbA1c testing volume for outpatients decreased by up to 70% during the early months of the pandemic. The decrease in testing was associated with an increase in abnormal HbA1c results.
format Online
Article
Text
id pubmed-8080532
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-80805322021-04-29 The effect of the Covid-19 shutdown on glycemic testing and control Sharma, Anu Greene, Dina N. Chambliss, Allison B. Farnsworth, Christopher W. French, Deborah Herman, Daniel S. Kavsak, Peter A. Merrill, Anna E. (Margaret) Lo, Sheng-Ying Lyon, Martha E. Winston-McPherson, Gabrielle Pearson, Lauren N. SoRelle, Jeffrey A. Waring, Avantika C. Schmidt, Robert L. Clin Chim Acta Article BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic caused a halt to in-person ambulatory care. We evaluated how the reduction in access to care affected HbA1c testing and patient HbA1c levels. METHODS: HbA1c data from 11 institutions were extracted to compare testing volume and the percentage of abnormal results between a pre-pandemic period (January-June 2019, period 1) and a portion of the COVID-19 pandemic period (Jan-June 2020, period 2). HbA1c results greater than 6.4% were categorized as abnormal. RESULTS: HbA1C testing volumes decreased in March, April and May by 23, 61 and 40% relative to the corresponding months in 2019. The percentage of abnormal results increased in April, May and June (25, 23, 9%). On average, we found that the frequency of abnormal results increased by 0.31% for every 1% decrease in testing volume (p < 0.0005). CONCLUSION: HbA1c testing volume for outpatients decreased by up to 70% during the early months of the pandemic. The decrease in testing was associated with an increase in abnormal HbA1c results. Elsevier B.V. 2021-08 2021-04-28 /pmc/articles/PMC8080532/ /pubmed/33932408 http://dx.doi.org/10.1016/j.cca.2021.04.018 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Sharma, Anu
Greene, Dina N.
Chambliss, Allison B.
Farnsworth, Christopher W.
French, Deborah
Herman, Daniel S.
Kavsak, Peter A.
Merrill, Anna E.
(Margaret) Lo, Sheng-Ying
Lyon, Martha E.
Winston-McPherson, Gabrielle
Pearson, Lauren N.
SoRelle, Jeffrey A.
Waring, Avantika C.
Schmidt, Robert L.
The effect of the Covid-19 shutdown on glycemic testing and control
title The effect of the Covid-19 shutdown on glycemic testing and control
title_full The effect of the Covid-19 shutdown on glycemic testing and control
title_fullStr The effect of the Covid-19 shutdown on glycemic testing and control
title_full_unstemmed The effect of the Covid-19 shutdown on glycemic testing and control
title_short The effect of the Covid-19 shutdown on glycemic testing and control
title_sort effect of the covid-19 shutdown on glycemic testing and control
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080532/
https://www.ncbi.nlm.nih.gov/pubmed/33932408
http://dx.doi.org/10.1016/j.cca.2021.04.018
work_keys_str_mv AT sharmaanu theeffectofthecovid19shutdownonglycemictestingandcontrol
AT greenedinan theeffectofthecovid19shutdownonglycemictestingandcontrol
AT chamblissallisonb theeffectofthecovid19shutdownonglycemictestingandcontrol
AT farnsworthchristopherw theeffectofthecovid19shutdownonglycemictestingandcontrol
AT frenchdeborah theeffectofthecovid19shutdownonglycemictestingandcontrol
AT hermandaniels theeffectofthecovid19shutdownonglycemictestingandcontrol
AT kavsakpetera theeffectofthecovid19shutdownonglycemictestingandcontrol
AT merrillannae theeffectofthecovid19shutdownonglycemictestingandcontrol
AT margaretloshengying theeffectofthecovid19shutdownonglycemictestingandcontrol
AT lyonmarthae theeffectofthecovid19shutdownonglycemictestingandcontrol
AT winstonmcphersongabrielle theeffectofthecovid19shutdownonglycemictestingandcontrol
AT pearsonlaurenn theeffectofthecovid19shutdownonglycemictestingandcontrol
AT sorellejeffreya theeffectofthecovid19shutdownonglycemictestingandcontrol
AT waringavantikac theeffectofthecovid19shutdownonglycemictestingandcontrol
AT schmidtrobertl theeffectofthecovid19shutdownonglycemictestingandcontrol
AT sharmaanu effectofthecovid19shutdownonglycemictestingandcontrol
AT greenedinan effectofthecovid19shutdownonglycemictestingandcontrol
AT chamblissallisonb effectofthecovid19shutdownonglycemictestingandcontrol
AT farnsworthchristopherw effectofthecovid19shutdownonglycemictestingandcontrol
AT frenchdeborah effectofthecovid19shutdownonglycemictestingandcontrol
AT hermandaniels effectofthecovid19shutdownonglycemictestingandcontrol
AT kavsakpetera effectofthecovid19shutdownonglycemictestingandcontrol
AT merrillannae effectofthecovid19shutdownonglycemictestingandcontrol
AT margaretloshengying effectofthecovid19shutdownonglycemictestingandcontrol
AT lyonmarthae effectofthecovid19shutdownonglycemictestingandcontrol
AT winstonmcphersongabrielle effectofthecovid19shutdownonglycemictestingandcontrol
AT pearsonlaurenn effectofthecovid19shutdownonglycemictestingandcontrol
AT sorellejeffreya effectofthecovid19shutdownonglycemictestingandcontrol
AT waringavantikac effectofthecovid19shutdownonglycemictestingandcontrol
AT schmidtrobertl effectofthecovid19shutdownonglycemictestingandcontrol